Plant-Derived Anti-Human Epidermal Growth Factor Receptor 2 Antibody Suppresses Trastuzumab-Resistant Breast Cancer with Enhanced Nanoscale Binding
Chanyong Park,Kibum Kim,Yerin Kim,Rong Zhu,Lisa Hain,Hannah Seferovic,Min-Hyeok Kim,Hyun Joo Woo,Hyunju Hwang,Seung Ho Lee,Sangmin Kim,Jeong Eon Lee,Peter Hinterdorfer,Kisung Ko,Sungsu Park,Yoo Jin Oh
DOI: https://doi.org/10.1021/acsnano.4c00360
IF: 17.1
2024-05-21
ACS Nano
Abstract:Traditional monoclonal antibodies such as Trastuzumab encounter limitations when treating Human Epidermal Growth Factor Receptor 2 (HER2)-positive breast cancer, particularly in cases that develop resistance. This study introduces plant-derived anti-HER2 variable fragments of camelid heavy chain domain (VHH) fragment crystallizable region (Fc) KEDL(K) antibody as a potent alternative for overcoming these limitations. A variety of biophysical techniques, in vitro assays, and in vivo experiments...
materials science, multidisciplinary,chemistry, physical,nanoscience & nanotechnology